Resources

0

Featured Resources

DolPHIN2 Infographic

The DolPHIN 2 Clinical Trial is designed to yield high-quality evidence on the efficacy and safety of dolutegravir in late presenting pregnant women, to allow definitive recommendations for use of dolutegravir to reduce MTCT in this high-risk scenario.

HIV on Trial

Meet our research team, hear from some of our research participants and learn more about the DolPHIN story so far.

1

Introducing a new HIV drug – three times faster

Unitaid show how they led the way in introducing dolutegravir three years faster than previous drugs.

Empower, Engage, Educate - Breastfeeding

Empower, Engage, Educate - Delivery

Empower, Engage, Educate - Male Involvement

Empower, Engage, Educate - Mumbwa

Empower, Engage, Educate - Safety

Empower, Engage, Educate - Adherence

Empower, Engage, Educate - Disclosure

Empower, Engage, Educate - Diagnosis

DolPHIN2 Infographic

The DolPHIN 2 Clinical Trial is designed to yield high-quality evidence on the efficacy and safety of dolutegravir in late presenting pregnant women, to allow definitive recommendations for use of dolutegravir to reduce MTCT in this high-risk scenario.

HIV on Trial

Meet our research team, hear from some of our research participants and learn more about the DolPHIN story so far.

They become strong when they see me doing this

Jackie Kyeyune, a peer mother living with HIV, discusses how she uses her lived experience to support and inspire the DolPHIN 2 trial participants.

Pages